Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast
12 Marzo 2024 - 11:30PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that the company has scheduled the release
of its fourth quarter and full year 2023 financial results before
the market opens on Wednesday, March 13, 2024.
The Company will hold a conference call at 4:30 p.m. Eastern on
Wednesday, March 13, which will be open to the public. During the
conference call, the company will review its financial results and
provide business updates.
Participants should register for, and access, the call using
this link. While not required, it is recommended to join 10 minutes
prior to the event start. Once registered, participants will be
given the option to either dial into the call with the number and
unique passcode provided, or to use the dial-out option to connect
their phone instantly. The link to access the live webcast can also
be found on the Sangamo Therapeutics website in the Investors and
Media section under Events.
A replay will be available following the conference call,
accessible under Events.
About Sangamo Therapeutics
Sangamo Therapeutics is a genomic medicine company dedicated to
translating ground-breaking science into medicines that transform
the lives of patients and families afflicted with serious
neurological diseases who do not have adequate or any treatment
options. Sangamo’s zinc finger epigenetic regulators are ideally
suited to potentially address devastating neurological disorders
and Sangamo’s capsid discovery platform is expanding delivery
beyond currently available intrathecal delivery capsids, including
in the central nervous system. Sangamo’s pipeline also includes
multiple partnered programs and programs with opportunities for
partnership and investment. To learn more, visit www.sangamo.com
and connect with us on LinkedIn and Twitter/X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240312863070/en/
Investor & Media Inquiries
Louise Wilkie ir@sangamo.com media@sangamo.com
Grafico Azioni Sangamo Therapeutics (NASDAQ:SGMO)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Sangamo Therapeutics (NASDAQ:SGMO)
Storico
Da Mag 2023 a Mag 2024